ArticleJCI insight2019

Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor.

Michael V Ortiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.